The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers

Alec J. Kacew; Allison C. Grimes; Michael Roth; Deanna Teoh; Wendy Landier; Garth W. Strohbehn; Electra D. Paskett

doi:10.3322/caac.21649

The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers

Alec J. Kacew, Allison C. Grimes, Michael Roth, Deanna Teoh, Wendy Landier, Garth W. Strohbehn, Electra D. Paskett

Producción científica: Letter › revisión exhaustiva

Idioma original	English (US)
Páginas (desde-hasta)	518-519
Número de páginas	2
Publicación	CA Cancer Journal for Clinicians
Volumen	70
N.º	6
DOI	https://doi.org/10.3322/caac.21649
Estado	Published - nov 1 2020

ASJC Scopus subject areas

Hematology
Oncology

Acceder al documento

10.3322/caac.21649

Otros archivos y enlaces

Citar esto

@article{b73d27d59ac24456a673bff91256a624,

title = "The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers",

author = "Kacew, {Alec J.} and Grimes, {Allison C.} and Michael Roth and Deanna Teoh and Wendy Landier and Strohbehn, {Garth W.} and Paskett, {Electra D.}",

note = "Funding Information: Alec J. Kacew has received research support from the Pritzker School of Medicine and the American Society of Hematology for work performed outside of the current study. Allison C. Grimes has received grants from the Cancer Prevention Research Institute of Texas for work performed outside of the current study. Deanna Teoh has received grants from Acelity and salary support for her role as a local principal investigator for an industry‐sponsored trial from GlaxoSmithKline for work performed outside of the current study. Wendy Landier has received grants from the National Cancer Institute of the National Institutes of Health and nonfinancial support to her institution from Merck, Sharp & Dohme for work performed outside of the current study. Garth W. Strohbehn's institution has received fellowship funding support from Abbott Laboratories Inc and he holds a filed provisional patent not applicable to the current study. Electra D. Paskett has received grants from the National Cancer Institute of the National Institutes of Health for work performed as part of the current study and has received grants from the Merck Foundation, Pfizer, the Breast Cancer Research Foundation, Foxconn, and the One Family Foundation for work performed outside of the current study. Michael Roth made no disclosures.",

year = "2020",

month = nov,

day = "1",

doi = "10.3322/caac.21649",

language = "English (US)",

volume = "70",

pages = "518--519",

journal = "CA Cancer Journal for Clinicians",

issn = "0007-9235",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - The case for catch-up human papillomavirus vaccination in at-risk populations

T2 - Rural communities and survivors of pediatric and young adult cancers

AU - Kacew, Alec J.

AU - Grimes, Allison C.

AU - Roth, Michael

AU - Teoh, Deanna

AU - Landier, Wendy

AU - Strohbehn, Garth W.

AU - Paskett, Electra D.

N1 - Funding Information: Alec J. Kacew has received research support from the Pritzker School of Medicine and the American Society of Hematology for work performed outside of the current study. Allison C. Grimes has received grants from the Cancer Prevention Research Institute of Texas for work performed outside of the current study. Deanna Teoh has received grants from Acelity and salary support for her role as a local principal investigator for an industry‐sponsored trial from GlaxoSmithKline for work performed outside of the current study. Wendy Landier has received grants from the National Cancer Institute of the National Institutes of Health and nonfinancial support to her institution from Merck, Sharp & Dohme for work performed outside of the current study. Garth W. Strohbehn's institution has received fellowship funding support from Abbott Laboratories Inc and he holds a filed provisional patent not applicable to the current study. Electra D. Paskett has received grants from the National Cancer Institute of the National Institutes of Health for work performed as part of the current study and has received grants from the Merck Foundation, Pfizer, the Breast Cancer Research Foundation, Foxconn, and the One Family Foundation for work performed outside of the current study. Michael Roth made no disclosures.

PY - 2020/11/1

Y1 - 2020/11/1

UR - http://www.scopus.com/inward/record.url?scp=85092572515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092572515&partnerID=8YFLogxK

U2 - 10.3322/caac.21649

DO - 10.3322/caac.21649

M3 - Letter

C2 - 33063840

AN - SCOPUS:85092572515

SN - 0007-9235

VL - 70

SP - 518

EP - 519

JO - CA Cancer Journal for Clinicians

JF - CA Cancer Journal for Clinicians

IS - 6

ER -